Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro
- 4 November 2023
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (12) , 10189-10198
Abstract
Background Ovarian cancer remains a common gynecological tumor and the fifth leading cause of death worldwide. Taxol-based chemotherapy is a standard approach to the treatment of ovarian cancer. Glutathione peroxidase 4 (GPX4) is the key regulator of ferroptosis, which is an important form of cell death. Here, we investigate the effect of GPX4 inhibition-mediated ferroptosis on the sensitivity of ovarian cancer cells to Taxol. Methods and results A2780/PTX and OVCAR-3/PTX Taxol-resistant ovarian cancer cells were established, and stable GPX4 knockout cell lines were generated via lentivirus GPX4-sgRNA. The GPX4 expression level, the apoptosis rate and cell viability were analyzed. The levels of ferroptosis-related factor indicators such as malondialdehyde (MDA) and reactive oxygen species (ROS) were measured. The results showed that the GPX4 protein and mRNA levels were increased in the Taxol-resistant cells. Moreover, GPX4 knockout reduced cell viability and inhibited the colony formation rate. In addition, we found that GPX4 inhibition increased Taxol sensitivity by inducing ferroptosis. Conclusions In summary, our studies reveal that GPX4 inhibition promotes ferroptosis and increases the sensitivity of ovarian cancer cells to Taxol in vitro.Keywords
Funding Information
- Shenzhen Healthcare Research Project (SZLY2017030)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201812075)
- Shenzhen Science and Technology Innovation Program (JCYJ20210324134413038)
- National Natural Science Foundation of China (82103124)
This publication has 29 references indexed in Scilit:
- Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cellsScientific Reports, 2017
- Ferroptosis: bug or feature?Immunological Reviews, 2017
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and ParalysisJournal of Biological Chemistry, 2015
- Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?Cancer Chemotherapy and Pharmacology, 2014
- Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedinCancer Treatment Reviews, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- Second-Line Treatment of Ovarian CancerThe Oncologist, 2000
- Treatment of advanced epithelial ovarian cancer: past, present and futureCritical Reviews in Oncology/Hematology, 1995